id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
945907,9fc76cee-6906-4c38-a406-8d318a0600ce,Q2,ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH,113,ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH,2010,second_quarter,MED,FEDERAL FUNDING FOR THE NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING AT THE NATIONAL INSTITUTES OF HEALTH,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-06-07T11:00:43.720000-04:00
946635,f6719352-3cf9-4fc3-a8ef-8544abe336fa,Q2,HOLLAND & KNIGHT LLP,18466,ALLIANCE FOR REGENERATIVE MEDICINE,2010,second_quarter,MED,Advocate for funding for regenerative medicine companies; Advocate for NIH funding for regenerative medicine research.,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",60000,,0,0,2010-06-28T11:25:48.423000-04:00
946684,ede8552c-661c-47d8-bae8-7235d595695a,Q2,HOLLAND & KNIGHT LLP,18466,"Q THERAPEUTICS, INC.",2010,second_quarter,MED,Work to secure funding in Department of Defense Appropriations bill for FY 2011 to fund research regarding treatment for spinal cord injury.,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-06-28T12:45:15.273000-04:00
946815,6ef5ef96-3574-4f95-bd57-02bfdb1eebb8,Q2,HOLLAND & KNIGHT LLP,18466,AMERICAN SOCIETY OF HEMATOLOGY,2010,second_quarter,MED,"Labor, HHS, Education Appropriations bills; hematology  and hematology/oncology public health and research issues; Health Reform Legislation; HR 1230 Bone Marrow Failure Disease Research and Treatment Act.","Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-06-29T13:22:49.667000-04:00
946821,d67793e3-bf4d-4bbd-9971-337eb79870ea,Q2,HOLLAND & KNIGHT LLP,18466,NATIONAL HEMOPHILIA FOUNDATION,2010,second_quarter,MED,Biomedical Research; CDC Hemophilia program; HR 4846 SAFE Act,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",40000,,0,0,2010-06-29T13:27:54.447000-04:00
946826,8015af12-d5a5-4d56-9dee-05caaf2913c8,Q2,HOLLAND & KNIGHT LLP,18466,AABB,2010,second_quarter,MED,Issues related to blood transfusion; tissue transplantation and other laboratory services; blood safety issues; biovigilance programs at CDC and HHS.,"Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-06-29T13:34:00.557000-04:00
947168,bf02adb1-a242-46ff-bb59-1d2abd4b94b4,2T,MIKE SLOTZNICK,400457200,"PHARMACEUTICAL MARKETING RESEARCH GROUP, INC.",2010,second_quarter,MED,"Physician Payments Sunshine Act of 2009 (S. 301, H.R. 3138) -- applicability to survey research activities.","HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2010-07-01T22:14:59.303000-04:00
947203,af01a255-35f8-459a-b89e-8dd1a33c66d6,Q2,MARSHALL BRACHMAN,6848,CARDIOVASCULAR OUTPATIENT CENTER ALLIANCE,2010,second_quarter,MED,"support HR 1293/S. 1338 equivalent in 111th Congress
reverse cardiac catheterization practice expense cuts","HOUSE OF REPRESENTATIVES,SENATE",12000,,0,0,2010-07-02T10:19:13.267000-04:00
947237,a29b5ca6-1a1c-47c3-85b5-fff313e2c594,Q2,MARSHALL BRACHMAN,6848,ST VINCENT MEDICAL GROUP FORMERLY KNOWS AS THE CARE GROUP LLC,2010,second_quarter,MED,oppose cuts to diagnostic imaging in any legislative vehicles;reverse outpatient cardiac catheterization practice expense cuts; support accreditation model for diagnostic imaging in HR 3200 and equivalent Senate legislation; support HR 4173 to reverse cuts in 2010 PFS rule,"HOUSE OF REPRESENTATIVES,SENATE",9000,,0,0,2010-07-02T10:51:26.940000-04:00
947256,72f669c8-9a74-42eb-a8e3-b420dffda3eb,Q2,MARSHALL BRACHMAN,6848,BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM,2010,second_quarter,MED,support funding for medical research programs,"HOUSE OF REPRESENTATIVES,SENATE",33000,,0,0,2010-07-02T11:09:31.067000-04:00
947262,5313473c-fd2a-4a5e-a6c8-b5e7b4c31d0c,Q2,"FRANCIS EDWARD & CRONIN, INC.",311314,CURE ALZHEIMER'S FUND,2010,second_quarter,MED,Legislation and issues related to Alzheimer's Disease Research,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",10000,,0,0,2010-07-02T11:16:26.217000-04:00
947470,0d831fa8-7c62-455b-b252-121503725b0d,Q2,"LAWRENCE J. SMITH, P.A.",35775,NATIONWIDE LABORATORY SERVICES,2010,second_quarter,MED,Medicare - End Stage Renal Disease.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-06T11:10:05.203000-04:00
947514,2415b7d2-8e77-45a5-b895-1532fb9b36a2,Q2,"BOLTON-ST. JOHNS, LLC",302290,"AMDEC FOUNDATION, INC.",2010,second_quarter,MED,Issues relating to grant funding for biomedical research.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-06T12:38:08.197000-04:00
947590,08fb4bc9-80d5-4e17-b304-f189697e367b,Q2,THE HARRIS FIRM,68376,DIRECT MESSAGE LAB,2010,second_quarter,MED,Regarding funding for FY 11 pertaining to software communication system for chronic disease management,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-06T15:04:51.603000-04:00
947611,1f8cb3fc-fcd7-4720-8498-af84be1acfd8,Q2,"RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)",400361684,"VIJUK EQUIPMENT, INC.",2010,second_quarter,MED,all issues related to pharmaceutical  labeling,,25000,,0,0,2010-07-06T15:28:55.313000-04:00
947689,48efbc1a-1358-444a-b606-67fe3c15bb0f,Q2,ASSN OF MEDICAL DEVICE REPROCESSORS,291732,ASSN OF MEDICAL DEVICE REPROCESSORS,2010,second_quarter,MED,"Educated Congressional staff, members of Congress, and FDA officials on FDA-regulated, third-party reprocessing industry.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",,20000,0,0,2010-07-07T10:15:59.910000-04:00
947761,dbcaa65a-f060-4e84-b0f4-232bdd845223,Q2,MAYO CLINIC,400270238,MAYO CLINIC,2010,second_quarter,MED,Cancer research,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,240000,0,0,2010-07-07T12:58:08.293000-04:00
947880,c7090d6f-4708-4564-ac13-4c513a8acade,Q2,"FEDERAL SOLUTIONS, LLC",311371,JACKSONVILLE STATE UNIVERSITY,2010,second_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research, education, and development","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-07T15:05:52.667000-04:00
947887,c5bed79a-3e90-41b1-b9fc-d732f88ff5f7,Q2,"FEDERAL SOLUTIONS, LLC",311371,MISSISSIPPI STATE UNIVERSITY,2010,second_quarter,MED,"Labor/HHS/Education Appropriations Bill, 2010: Provisions relating to disease research","Agriculture, Dept of (USDA),Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Aeronautics & Space Administration (NASA),Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2010-07-07T15:08:56.637000-04:00
947931,d58de490-c00e-4e6b-a11d-d2322c7f8ab8,Q2,AMERICAN COLLEGE OF CLINICAL PHARMACY,57258,AMERICAN COLLEGE OF CLINICAL PHARMACY,2010,second_quarter,MED,Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and  Medicare Part D plans.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",,54750,0,0,2010-07-07T15:29:08.027000-04:00
948595,8caa2244-5361-49ca-915f-3c22ec9ab171,Q2,"CORNERSTONE GOVERNMENT AFFAIRS, INC.",75557,PARENT PROJECT MUSCULAR DYSTROPHY,2010,second_quarter,MED,"Reauthorization for the Muscular Dystrophy Care Act
Funding for CDC, NIH, HHS, and FDA related to Muscular Dystrophy and other health research","HOUSE OF REPRESENTATIVES,SENATE",70000,,0,0,2010-07-08T18:06:53.973000-04:00
949309,8e9e8e5a-45c5-46a3-a4f9-17329cb5b0b4,Q2,"CAPITOL CONSULTING GROUP, LLC",400366700,"EMERGENCY PRESERVATION AND RESUSITATION TECHNOLOGIES, INC",2010,second_quarter,MED,"FY11 defense appropriations bill, medical research and development project regarding emergency profound hyperthermia for advanced casualty care","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-10T08:33:13.317000-04:00
949317,3dd4db9a-0a4d-40ff-8f0b-0acb304a297c,Q2,"CAPITOL CONSULTING GROUP, LLC",400366700,"FLAGSHIP GOVERNMENT RELATIONS, INCORPORATED",2010,second_quarter,MED,"FY 11 defense appropriations bill,  medical research and development","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-10T09:00:16.597000-04:00
949322,ee77665d-475d-4b06-83d6-1e21bddd1446,Q2,"CAPITOL CONSULTING GROUP, LLC",400366700,LIFECELL CORPORATION,2010,second_quarter,MED,"FY11 defense appropriations bill, Army medical research and development project","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-10T09:24:19.207000-04:00
949578,32699647-9669-4b65-84f7-697e86e17959,Q2,"THE CJR GROUP, INC.",288293,UNIVERSITY HOSPITALS HEALTH SYSTEM,2010,second_quarter,MED,Medical issues relating to hospitals,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-12T10:32:30.850000-04:00
949610,5b0370fb-3e6d-4e6a-b236-bb60fa80a07b,Q2,NATIONAL VENTURE CAPITAL ASSOCIATION,21687,NATIONAL VENTURE CAPITAL ASSOCIATION,2010,second_quarter,MED,FDA Preemption: S540 and HR1346 Medical Device Safety Act of 2009,"Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Patent & Trademark Office (PTO),Securities & Exchange Commission (SEC),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office",,826066,0,0,2010-07-12T11:14:31.597000-04:00
949899,9723f837-9546-4d14-8e11-50adb6b937b0,Q2,MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP),24486,"BIOCRYST PHARMACEUTICALS, INC.",2010,second_quarter,MED,Federal response to the H1N1 influenze pandemic and overall prepardness,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-12T14:15:28.747000-04:00
950071,547958b1-776d-4a2c-8b88-e6a99a36535d,Q2,BEN BARNES GROUP LP,5415,HUNTSMAN CANCER INSTITUTE,2010,second_quarter,MED,Assistance with issues relating to medical research,"HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-12T15:46:55.717000-04:00
950259,88bb6598-e936-497a-bab2-10e65c3d0a75,Q2,PREVENT BLINDNESS,78312,PREVENT BLINDNESS,2010,second_quarter,MED,Eye Disease; Treatment and Prevention of Blindness and Vision Loss,"Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",,44923,0,0,2010-07-12T17:36:04.920000-04:00
950395,799e8bd3-1fa7-47ef-a9c2-604630aa3919,Q2,"LEE & SMITH, PC",22440,NORTH DAKOTA STATE UNIVERSITY (NDSU),2010,second_quarter,MED,"(1)  House and Senate FY2011 Labor, Health and Human Services Appropriations Bill (still unnumbered), U.S. Department of Health and Human Services, Health Resources Services Administration (HRSA); Issue:  Biomedical Research Infrastructure Improvement at North Dakota State University.","Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE",50000,,0,0,2010-07-13T01:45:25.427000-04:00
951098,d1e10d23-3cf0-418a-a93c-1ca92b5422a1,Q2,"PAUL MARCONE & ASSOCIATES, LLC",283732,PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE,2010,second_quarter,MED,Getting Congress to stop federal funding of a specific grant awarded by NASA for radiation studies involving the use of live squirrel monkeys and designed to predict radiation risks for astronauts during deep space travel.,"HOUSE OF REPRESENTATIVES,SENATE",24000,,0,0,2010-07-13T13:17:20.250000-04:00
951495,ea60a9e4-6e40-4eeb-8aae-b071c7098e2c,Q2,BEN BARNES GROUP LP,5415,OKLAHOMA RESEARCH MEDICAL FOUNDATION,2010,second_quarter,MED,Issues relating to medical research,"HOUSE OF REPRESENTATIVES,SENATE",13400,,0,0,2010-07-13T14:59:01.860000-04:00
951689,87416cb9-9402-4d9c-97bf-bb83f6c09426,Q2,TOURETTE ASSOCIATION OF AMERICA,87494,TOURETTE ASSOCIATION OF AMERICA,2010,second_quarter,MED,Tourette Syndrome Research,"Centers For Disease Control & Prevention (CDC),Education, Dept of,HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Social Security Administration (SSA)",,70000,0,0,2010-07-13T15:51:15.017000-04:00
951716,077103fb-fa15-437f-9d8b-e38e393ca262,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,AIDS HEALTHCARE FOUNDATION,2010,second_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010 -  Support funding for medical treatment for HIV positive patients.  Not introduced.

Continue appropriate funding levels for Chronic Care Special Needs clinics under Medicare.","Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-13T15:56:02.780000-04:00
951896,d4eb10c2-aaee-4871-bd6e-66e529e1bc48,Q2,DENNY MILLER ASSOCIATES,25328,ST PATRICK HOSPITAL AND HEALTH SCIENCE CENTER,2010,second_quarter,MED,"FY2011 Dept. of Labor, Health and Human Services Appropriations, Title II, provisions related to mental health projects.
FY2011 Dept. of Defense Appropriations, Title IV, provisions related to Army medical research.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-13T16:47:55.553000-04:00
951913,897e4ade-0e49-4885-9724-e8b542675ad5,Q2,DENNY MILLER ASSOCIATES,25328,STB CORPORATION,2010,second_quarter,MED,"FY2011 Dept. of Defense Appropriations, TItle IV, RDT&E, issues pertaining to medical advanced technology
FY2009 DOD Appropriations, P.L. 111-32, issues pertaining to medical advanced technology","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-13T16:54:03.647000-04:00
951924,10f277a0-633e-4e8d-8a07-65792150dbf6,Q2,"MEHLMAN CONSULTING, INC.",284950,AMERICAN CLINICAL LABORATORY ASSOCIATION,2010,second_quarter,MED,"Health reform law implementation issues including application of medical device tax to clinical laboratory tests and cut to laboratory fee schedule update.     H.R. 4213/S. 3551, American Jobs and Closing Tax Loopholes Act of 2010:  health care provisions including physician payment (SGR), FMAP and Cobra.     H.R. 5440, Genomics and Personalized Medicine Act of 2010:  FDA oversight of laboratory developed tests (LDTs).","HOUSE OF REPRESENTATIVES,SENATE",60000,,0,0,2010-07-13T16:56:41.587000-04:00
952352,7bfd6eec-2371-44d3-9399-92ab80dab17b,Q2,"WHITMER & WORRALL, LLC",292892,NEURO KINETICS,2010,second_quarter,MED,Issues related to Traumatic Brain Injury (TBI).,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-14T10:36:04.777000-04:00
952368,e2a199b4-fba5-4f46-a9b2-3e9bec9c4c1e,Q2,RAY C CULVER III,11468,ARKANSAS CHILDREN'S HOSPITAL,2010,second_quarter,MED,Funding for USDA Agricultural Research Service human nutrition centers in the FY2011 Agricultural Appropriations bill,"HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-14T10:44:13.180000-04:00
953001,26bdbbad-0ef5-4d00-a57f-37f5d9c041d6,Q2,"O'NEILL, ATHY & CASEY, P.C.",42752,MASS GENERAL BRIGHAM,2010,second_quarter,MED,"Funding for federally-sponsored medical research
American Recovery and Reinvestment Act","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),White House Office",150000,,0,0,2010-07-14T14:24:50.963000-04:00
953709,9b609840-0046-4cd1-bf0e-210a3fd611b0,Q2,"M.J. SIMON & COMPANY, LLC",40026223,AXOGEN INC.,2010,second_quarter,MED,Food and Drug Act,"Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",36000,,0,0,2010-07-14T21:23:04.220000-04:00
953851,bbdc417d-1ead-4442-bf03-532d97a59e31,Q2,"KSCW, INC.",21596,INTERNATIONAL ASSOCIATION OF MEDICAL EQUIPMENT REMARKETERS AND SERVICERS (IAMERS,2010,second_quarter,MED,"HR1346, S540 Medical Device Safety Act of 2009: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting devices.",HOUSE OF REPRESENTATIVES,10000,,0,0,2010-07-15T08:59:53.433000-04:00
953931,d4f5634c-ce45-4e29-9814-f2edd679a885,Q2,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,314055,THE NATIONAL ALLIANCE FOR EYE AND VISION RESEARCH,2010,second_quarter,MED,Support for the National Institutes of Health; Support for the National Eye Institute; Support for medical research programs at the Department of Defense,"HOUSE OF REPRESENTATIVES,SENATE",,76000,0,0,2010-07-15T10:32:50.107000-04:00
954229,4d7f4303-8df5-4661-bcd1-51c18e5d0497,Q2,BUTZEL LONG TIGHE PATTON PLLC,45298,"ASPEN MEDICAL USA, INC.",2010,second_quarter,MED,"Health care services to Guam, Pacific Islands, and DOD.  Health care services to DOD.","HOUSE OF REPRESENTATIVES,Navy, Dept of",20000,,0,0,2010-07-15T11:38:16.950000-04:00
954251,722c41c4-d7f5-4f4e-a0bd-69294b4e0b35,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,COOLEY'S ANEMIA FOUNDATION,2010,second_quarter,MED,Drug review and approval process,"Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-15T11:43:30.310000-04:00
954432,5fa83626-49d9-4927-a1b9-0297658e6ec2,Q2,PARALYZED VETERANS OF AMERICA,30724,PARALYZED VETERANS OF AMERICA,2010,second_quarter,MED,"Department of Veterans Affairs, Medical Research Issues
National Institutes of Health, Medical Research Issues","HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)",,85026,0,0,2010-07-15T12:51:10.357000-04:00
954451,5a3ba48b-df90-4a78-9914-44a79c2e0358,Q2,POLICY DIRECTIONS INC.,31747,ADVANCED LIFE SCIENCES,2010,second_quarter,MED,"FDA regulatory pathway for new antibiotic medicines.
HR 2400, Strategies to Address Antimicrobial Resistance Act, portions related to introduction of and regulatory policy of new antimicrobial candidates.","Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-15T12:53:14.060000-04:00
954507,86805fa7-8c01-4cf2-9ee4-26f62cce64d6,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,STATE UNIVERSITY SYSTEM OF FLORIDA,2010,second_quarter,MED,Appropriations and Authorization legislation for FY 2011 in health care,"Agriculture, Dept of (USDA),Defense, Dept of (DOD),Education, Dept of,Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),SENATE",70000,,0,0,2010-07-15T13:12:42.620000-04:00
954591,f18bdd6b-f647-47a0-8870-fad432062094,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,APLASTIC ANEMIA & MDS INTERNATIONAL FOUNDATION,2010,second_quarter,MED,"No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, biomedical research
No Bill#, Defense Appropriations Bill, FY 2011, research for bone marrow failure disease
HR 1230, Bone Marrow Failure Disease Research and Treatment Act","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-07-15T13:33:11.433000-04:00
954609,47197431-5a4c-4c68-a0c7-4bf7bf8c8c40,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,TUBEROUS SCLEROSIS ALLIANCE,2010,second_quarter,MED,"No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, Tuberous Sclerosis
No Bill#, Defense Appropriations Bill, FY 2011, Tuberous Sclerosis Complex Research Program","Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",20000,,0,0,2010-07-15T13:35:17.747000-04:00
954664,ff8eb4b6-07da-4bb3-b2e7-426e172b5e50,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"BRAIDWOOD MANAGEMENT, INC.",2010,second_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation has been introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.   No specific legislation has been introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T13:42:33.073000-04:00
954681,a6191ad1-13fa-4303-88b7-3db324eb6d20,Q2,"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.",8511,U.S. SOCCER FOUNDATION,2010,second_quarter,MED,"Congressional Soccer Caucus
Federal grants for obesity prevention and gang prevention
No Bill#, Labor-HHS-Education Appropriations Bill, FY 2011, anti-obesity programs","Corporation for Natl & Community Service,Defense, Dept of (DOD),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE",10000,,0,0,2010-07-15T13:44:37.777000-04:00
954709,6d317398-d061-4cdc-a8be-654217272706,Q2,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,3435,AMERICAN SOCIETY FOR CLINICAL PATHOLOGY,2010,second_quarter,MED,"H.R. 1 American Recovery and Reinvestment Act of 2009
Stark Self-Referral Related Issues
Health Care Reform -- Tri Committee Draft Proposal Various Senate Finance Committee Drafts -- HELP Committee Drafts
Elimination of SGR Formula Under Medicare; HR 3962, the Affordable Health Care for America Act","Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),SENATE",,52400,0,0,2010-07-15T13:50:58.240000-04:00
954722,f675458d-8d65-47bb-bbc8-4d18515d159c,Q2,"DALRYMPLE & ASSOCIATES, LLC",5073,SANOFI PASTEUR,2010,second_quarter,MED,"Vaccine research and development legislation, funding, appropriations and oversight.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID),Veterans Affairs, Dept of (VA),White House Office",47000,,0,0,2010-07-15T13:53:53.497000-04:00
954749,07e5af63-5cc4-4589-abd5-366b151e8ae3,Q2,"DALRYMPLE & ASSOCIATES, LLC",5073,EMERGENT BIOSOLUTIONS INC (FORMERLY BIOPORT CORPORATION),2010,second_quarter,MED,"Biodefense and naturally-occurring vaccine and related biological products research and development funding, legislation, appropriations and oversight.","Army, Dept of (Other),Ballistic Missile Defense Organization,Centers For Disease Control & Prevention (CDC),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office",47000,,0,0,2010-07-15T13:59:03.513000-04:00
954757,831cb22b-4b9e-4a79-8680-28bb40ebc165,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"VETERINARY PHARMACIES OF AMERICA, INC.",2010,second_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T14:00:06.603000-04:00
954761,25bcabbf-7fff-4749-acb5-73852a10a2c1,Q2,"DALRYMPLE & ASSOCIATES, LLC",5073,"PULMATRIX, INC.",2010,second_quarter,MED,"Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.","Army, Dept of (Other),Centers For Disease Control & Prevention (CDC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Defense Threat Reduction Agency (DTRA),Executive Office of the President (EOP),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS)",16000,,0,0,2010-07-15T14:02:09.687000-04:00
954826,a7ec478c-527a-4edd-89ef-cdcd59d0ce29,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WOMEN'S INTERNATIONAL PHARMACY, INC.",2010,second_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T14:16:32.360000-04:00
955100,4cc586da-bc2c-41cc-bed8-dbc8307055d0,Q2,"PARRY, ROMANI, DECONCINI & SYMMS",30792,"WEDGEWOOD VILLAGE PHARMACY, INC.",2010,second_quarter,MED,"Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens.  No specific legislation introduced yet.
Legislation affecting the operation of compounding pharmacies and the availability of compounded medications.  No specific legislation introduced yet.","HOUSE OF REPRESENTATIVES,SENATE",11250,,0,0,2010-07-15T15:53:07.367000-04:00
955111,efbdf795-82dc-4063-a54e-37b3a55c8d51,Q2,CHARLIE MCBRIDE ASSOCIATES,24214,BIOMEDICAL RESEARCH FOUNDATION OF NORTHWEST LOUISIANA,2010,second_quarter,MED,To monitor legislation affecting medical energy research and technology-based economic development,"HOUSE OF REPRESENTATIVES,SENATE",7200,,0,0,2010-07-15T15:55:12.583000-04:00
955619,830ed7d2-3e3d-4190-9f09-9152b0330b7d,Q2,"THE WHITAKER GROUP, INC",312598,SAFE BLOOD INTERNATIONAL FOUNDATION FORMERLY SAFE BLOOD FOR AFRICA FOUNDATION,2010,second_quarter,MED,"To promote interest in, and support for, funding for blood safety programs, such as those conducted by Safe Blood for Africa Foundation, as an important means of preventing the spread of HIV/AIDS and other blood-borne diseases internationally, but primarily in Sub-Saharan Africa.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-15T17:37:55.410000-04:00
955681,b2ff8333-905f-41f6-a421-384f7c521321,Q2,CALIFORNIA LIFE SCIENCES,7758,CALIFORNIA LIFE SCIENCES,2010,second_quarter,MED,"Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education and strategic stockpilefunding and preparation.","HOUSE OF REPRESENTATIVES,SENATE",,160000,0,0,2010-07-15T18:13:49.037000-04:00
955707,04404cbd-1126-4a76-9fb8-48ac124db40a,Q2,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2970,"THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA)",2010,second_quarter,MED,No bill #:  Educate members and staff about occupational therapy research.,"Bureau of Labor Statistics (BLS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA),White House Office",,110000,0,0,2010-07-15T18:37:38.943000-04:00
956095,1ada50f1-709f-4e69-8cbf-91b5b7139a48,Q2,VAN SCOYOC ASSOCIATES,39837,BOSTON BIOCOM LLC,2010,second_quarter,MED,"Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, Biomedical research issues.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-16T08:06:51.873000-04:00
956354,1df2a935-5831-44db-838d-b1d892b4467f,Q2,"THE PETRIZZO GROUP, INC.",305932,"AGIOS PHARMACEUTICALS, INC.",2010,second_quarter,MED,Advance proposal for federal funding in the FY 2011 Defense Appropriations bill for cancer metabolism drug discovery that will bring therapeutic hope to service men and women who are suffering from Acut Myeloid Leukemia and brain cancer (gliomas).,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-16T10:54:01.890000-04:00
956400,4f1a360d-939a-4166-b19c-22b3a37afb70,Q2,"THE PETRIZZO GROUP, INC.",305932,ALLEN INSTITUTE,2010,second_quarter,MED,"Advocated for federal funding in the FY 2011 Labor HHS Appropriations bill for the Allen Institute Human Brain Atlas Project, which will create a comprehensive 3-dimensional map detailing gene expression in the human brain.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-16T11:00:14.877000-04:00
956402,f8118a11-309b-4a10-8a37-7a9fb2293a9e,Q2,MANATOS & MANATOS,23634,RWD TECHNOLOGIES,2010,second_quarter,MED,"Congressional or Executive Branch actions that affect the health care industry, particularly with regard to the elimination of waste in hospital procedures.","HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-16T11:01:16.017000-04:00
956632,96b76a24-45c8-4da3-9f7b-9b6a23b577dc,Q2,FOWLER COMMUNICATIONS INC,15257,SOUTH CAROLINA MEDICAL ASSOCIATION,2010,second_quarter,MED,amendment to existing ERISA authorizing a different distribution of assets in event of the dissolution of a multiple entitlement association,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-16T11:44:40.937000-04:00
956714,99326645-5fca-49c4-8acb-c927c83e397b,Q2,UNIVERSITY HOSPITALS HEALTH SYSTEM,305817,UNIVERSITY HOSPITALS HEALTH SYSTEM,2010,second_quarter,MED,"Medical issues relating to hospitals and physicians S. 353/HR 758 National Pediatric Research Consortium, childhood obesity legislation/activities; House Resolution 996 & Senate Resolution 412 (childhood obesity awareness month for Sept), Child Nutrition Reauthorization Act, S. 3307/H.R. 5504, Patient Centered Outcomes Research Institute sent nomination to GAO,","Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",,81775,0,0,2010-07-16T12:00:06.983000-04:00
956725,d763558f-5401-4eb5-93e8-aecf21a20c0a,Q2,"THE PETRIZZO GROUP, INC.",305932,BENAROYA RESEARCH INSTITUTE,2010,second_quarter,MED,"Advocated for federal funding in FY 2011 DoD Appropriations bill to develop personalized disease therapies based on genetic phenptype identification and specialized pre-symptomatic therapy for autoimmune disease.
Advocated for federal funding in FY 2011 LHHS Appropriations bill for critical multi-project animal care infrastructure.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-16T12:01:12.203000-04:00
957524,39ed318c-2a1d-40dc-a84d-a9232af5c26a,Q2,PRIME POLICY GROUP,400532589,UNIVERSITY OF MIAMI,2010,second_quarter,MED,"S. 693 - A bill to amend the Public Health Service Act to provide grants for the training of graduate medical residents in preventive medicine. S. 733 - A bill to ensure the continued and future availability of life saving trauma health care in the United States and to prevent further trauma center closures and downgrades by assisting trauma centers with uncompensated care costs, core mission services, and emergency needs.","HOUSE OF REPRESENTATIVES,SENATE",100000,,0,0,2010-07-16T14:19:36.843000-04:00
957701,4b179a51-3a43-4ff5-b321-071b4605cf36,2T,BABBAGE COFOUNDER,68478,ALLOSTATIX,2010,second_quarter,MED,Testing for post-traumatic stress disorder and other chronic illnesses.,"HOUSE OF REPRESENTATIVES,SENATE",,,0,1,2010-07-16T14:54:52.483000-04:00
958185,0d84a429-da05-4252-8d84-a5baf35f9cee,Q2,"WOMBLE CARLYLE SANDRIDGE & RICE, LLP",53505,GEOVAX LABS INC,2010,second_quarter,MED,To raise Congressional awareness regarding the need for an HIV/AIDS vaccine; Ryan White Act reauthorization issues,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-16T16:45:35.247000-04:00
958189,07ff2026-70f7-46ff-a6d0-163bb3d5f04e,Q2,MARTIN GREEN,400427061,FABIANI & COMPANY ON BEHALF OF OCTANE,2010,second_quarter,MED,Funding for innovation accelerator programs and conferences.,"Commerce, Dept of (DOC),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Science Foundation (NSF),SENATE,Small Business Administration (SBA)",,,0,0,2010-07-16T16:47:28.140000-04:00
958252,38730cf4-e6bd-4b5d-9c1d-f0bf264f556d,Q2,MARTIN GREEN,400427061,"FABIANI & COMPANY ON BEHALF OF CLINICAL DATA, INC.",2010,second_quarter,MED,The Genomics and Personalized Medicine Act of 2007; Realizing the potential of personalized medicine; and Exclusive licensure of genetic associations,"Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-16T16:54:51.577000-04:00
958269,e1e265d9-5874-4924-b69e-2caa236c50e6,Q2,MARTIN GREEN,400427061,FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS,2010,second_quarter,MED,Funding for drug and platform development,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2010-07-16T16:56:56.843000-04:00
958397,248299ff-f28d-4553-b042-d5c12fbd8c35,Q2,UNIVERSITY OF IOWA,49191,UNIVERSITY OF IOWA,2010,second_quarter,MED,"FY 2010 Appropriations                                                      S. 588; H.R. 1093 Residency Caps
H.R. 3; S. 5; S. 30 Stem Cell                                               S. 1576 Minority Improvement
S. 1066 Medical Affordability Act                                     H. R. 1788, S. 458 False Claims Correction Act
S. 484 Research Misconduct Clinical Trials                     NIOSH Education and Research Centers for Occupational Health and Safety Pathways for Biosimilars Act (H.R. 1548)
Prevention Research Centers
Resident Physician Shortage Reduction Act of 2009
Health Care Reform (H.R. 3590)","Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)",,110000,0,0,2010-07-16T17:28:41.297000-04:00
958534,fde5f645-fd52-4bde-b930-4e2c35703d44,Q2,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,GENWORTH FINANCIAL INC,2010,second_quarter,MED,Issues affecting long-term care insurance,"HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of,White House Office",90000,,0,0,2010-07-16T19:46:35.637000-04:00
958608,6c5b82f8-f846-4369-8ad8-280cd9d1d23a,Q2,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,MOBILE MEDICAL INTERNATIONAL CORPORATION,2010,second_quarter,MED,"Develop partnership with Veterans Administration (VA) to provide mobile surgery units (MSUs) throughout system when VA operating rooms are under construction or renovation, or additional capacity is needed soon, thus saving the VA money and other benefits.","SENATE,Veterans Affairs, Dept of (VA)",50000,,0,0,2010-07-16T20:50:01.797000-04:00
958740,c811b1b8-1e5f-477c-9c8d-c4e34626d5b9,Q2,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,Z-MEDICA CORPORATION,2010,second_quarter,MED,Issues relating to hemostatic blood clotting agents,"HOUSE OF REPRESENTATIVES,SENATE,U.S. International Development Cooperation Agency",60000,,0,0,2010-07-16T23:27:22.060000-04:00
958742,cf65cb62-5a00-40be-bd1c-21515d1561be,Q2,"BROWNSTEIN HYATT FARBER SCHRECK, LLP",7257,ZOLL DATA SYSTEMS,2010,second_quarter,MED,Issues relating to healthcare IT funding,"Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-16T23:30:23.530000-04:00
959019,00d6ca40-3e01-421f-9f83-2a24ea646b4e,Q2,"THE PETRIZZO GROUP, INC.",305932,"DESOTO MEMORIAL HOSPITAL, INC.",2010,second_quarter,MED,Advocated for Congressional support of appeak to FEMA regarding use of grant funding to reinforce the hospitals roof.,"HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-17T14:22:45.720000-04:00
959042,b32294fd-a7ed-49e7-8977-f2b61409eac4,Q2,"THE PETRIZZO GROUP, INC.",305932,"FATE THERAPEUTICS, INC.",2010,second_quarter,MED,"Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.","HOUSE OF REPRESENTATIVES,SENATE",25000,,0,0,2010-07-17T14:29:59.563000-04:00
959102,2408ee15-56eb-4340-9fbb-2ba3471709cb,Q2,"THE PETRIZZO GROUP, INC.",305932,FRED HUTCHINSON CANCER RESEARCH CENTER,2010,second_quarter,MED,Advocated in support of the 21st Century Cancer ALERT Act (S. 717).,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-17T14:39:29.860000-04:00
959230,c033ecae-d219-457a-b513-2faf31acec20,Q2,"THE PETRIZZO GROUP, INC.",305932,ORLANDO HEALTH,2010,second_quarter,MED,"As the Pediatric Neuroscience Institute at the Arnold Palmer Hospital for Children continues to align the services provided with the needs of the Central Florida community, this capability was identified as one that could dramatically improve the quality of life of children in the area. To eliminate wait times of 8-10 weeks and provide more advanced imaging services to patients, we are seeking funding to purchase a 3 Tesla MRI, which has substantially greater diagnostic capabilities than the current unit and would benefit all of the key service that support patients.

Orlando Healths Childrens Advocacy Center program. Advocate for federal funding that will ensure that the thousands of families that experience child abuse each year in Orange County, Florida are able to access the services needed to help them recover and heal. Funding will be used to sustain existing child advocates and therapists, and other costs, as well as expand the programs capacity to provide services, with the addition of two child advocates and four therapists. This will expand access to vital rehabilitation and recovery services for victims of child abuse. 

Orlando Healths M.D. Anderson Cancer Center Nano-medicine for Radiation Protection of U.S. Armed Forces. Advocate for federal funding to support a drug discovery program to improve the survival of, provide faster recovery for, and limit or eliminate drug side effects experienced by US military men and women after exposure to high levels of radiation. The funding will be used to create a platform where scientists can study the effect of radiation on nanoparticles with or without cells. Specifically, scientists will identify the form of nanoceria that provides the most effective level of radioprotection. This research will ultimately lead to the development of an effective drug for the treatment of radiation exposure for military personnel who are exposed to high doses of radiation during service to our country. This will be the first feasibility study of the effect of nano-medicine for radioprotection. The requested fudning will finance research on radioprotection for soldiers, and ultimately civilians, who must undergo radiation therapies for illnesses.","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-17T19:44:34.157000-04:00
959440,9eafe71b-729b-440c-a090-99e829af8777,2A,CHARLES DOUGHERTY,50284,SACRED HEART HOSPITAL,2010,second_quarter,MED,Medical Facilities and Expansion,"HOUSE OF REPRESENTATIVES,SENATE",,,0,0,2010-07-18T11:11:01.257000-04:00
959488,f474b96a-8ee0-46cd-8722-4936f8b70038,Q2,"STAPLETON & ASSOCIATES, LLC",40020147,"WAKE FOREST SCHOOL OF MEDICINE, INSTITUTE FOR REGENERATIVE MEDICINE",2010,second_quarter,MED,"Regenerative Medicine
Department of Defense Appropriations Act, Fiscal Year 2011.
National Defense Authorization Act for Fiscal Year 2011.","HOUSE OF REPRESENTATIVES,SENATE",10000,,0,0,2010-07-18T13:39:30.567000-04:00
959542,76214249-008e-4e97-8eac-32fa03ae96c5,Q2,BOB MOSS ASSOCIATES,51877,BURNHAM INSTITUTE FOR MEDICAL RESEARCH (NOW STANFORD-BURNHAM MEDICAL RESEARCH),2010,second_quarter,MED,"Securing continued federal support for Burnham's medical and scientific research, including the Department of Defense Appropriations Bil for FY11 (not yet introduced).","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-18T14:51:59.473000-04:00
959614,2486ea68-8a35-4d11-80c7-95608ad465df,Q2,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF CONCERT PHARMACEUTICALS,2010,second_quarter,MED,"Drug development for ocular infections, TBI/stroke related conditions, and HIV","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2010-07-18T17:26:24.230000-04:00
959630,faeb89d4-c5ff-4a64-9f0f-a4ea2f8fbdd8,Q2,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF TRIUS THERAPEUTICS,2010,second_quarter,MED,"Antibiotics, BioDefense","Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE",,,0,0,2010-07-18T17:36:30.277000-04:00
959642,4bd9f9a3-f39f-4629-a466-cb5a0f10e781,Q2,DANIELLE ORGAN PETERS,400427062,FABIANI & COMPANY ON BEHALF OF VARIATION BIOTECHNOLOGIES,2010,second_quarter,MED,Funding and parnerships with the Department of Defense and Department of Health and Human Services for vaccine research and development,"Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),Natl Institutes of Health (NIH)",,,0,0,2010-07-18T17:40:32.627000-04:00
959724,4a391ec2-83f3-4e51-b42a-180dc5f28c15,Q2,"THE PETRIZZO GROUP, INC.",305932,SEATTLE BIOMEDICAL RESEARCH INSTITUTE,2010,second_quarter,MED,Advocate for federal funding in the FY 2011 Defense Appropriations bill to support next - generation drug development for Leishmaniasis.,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-18T19:38:18.123000-04:00
959728,fff4a4a9-3c62-463c-8870-833efde3cea4,Q2,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CANCER CARE ALLIANCE,2010,second_quarter,MED,"Advocate for federal funding increases to support cancer disparity programs and additional research on cancer disparities, including examining clinical trial participation trends and barriers.  Early detection and access to state-of-the-art cancer care which will benefit the patient and reduce health care costs.","HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-18T19:40:19.500000-04:00
959731,401b9274-35db-4490-b6ea-384a5d7df07e,Q2,"THE PETRIZZO GROUP, INC.",305932,SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION,2010,second_quarter,MED,"Advocate for federal funding for GAPPS Project -- Understanding Increased Risk of Preterm Birth and Stillbirth in a Post-Combat Setting.  This request is aimed at improving our understanding of factors which contribute to preterm and stillbirths around the world.  Specifically, federal funding would examine how and whether poor nutrition, impoverishment, the high stress of living in war-torn areas, and exposure to various toxins and pathogens increase rates of preterm birth and stillbirth rates.  This project will provide the U.S. Army with research that will inspire new diagnostics, therapeutics and other innovations to improve birth outcomes and prevent prematurity and stillbirths. This research will extrapolate to a broader range of maternal health conditions as they relate to the priorities of the Department of Defense for warfighter health","HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-18T19:43:20.843000-04:00
959794,8edd6131-8b45-4258-a6ea-0dc49ac38084,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,ISIS PHARMACEUTICALS,2010,second_quarter,MED,"Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.","HOUSE OF REPRESENTATIVES,SENATE",15000,,0,0,2010-07-18T22:19:54.593000-04:00
959802,106be29b-0761-43aa-8d4b-fc390637a36d,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,MAYO CLINIC,2010,second_quarter,MED,"Address the safety, health and environmental concerns regarding the transport by railroad of hazardous commodities and coal traffic near the Rochester, Minnesota Mayo Clinic facility; more than 30,000 doctors and staff use this facility each day.  The multi-year Surface Transportation Authorization Act of 2009 (STAA) and the House THUD Subcommittee 2010 Transportation, Housing and Urban Development Appropriations Bill (H.R. 3288).","HOUSE OF REPRESENTATIVES,SENATE,Transportation, Dept of (DOT)",45000,,0,0,2010-07-18T22:31:58.893000-04:00
959814,3e56d737-8772-4543-a519-76cb41c8152e,Q2,MCDERMOTT WILL & SCHULTE LLP,24338,GENOMIC HEALTH INC,2010,second_quarter,MED,"FDA regulation of laboratory-developed tests.
Medicare reimbursement for laboratory-developed tests.","Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE",250000,,0,0,2010-07-18T23:01:06.797000-04:00
959919,e7dbd233-a4db-4ab9-bb5d-950de2c3a557,Q2,VAN SCOYOC ASSOCIATES,39837,UNIVERSITY OF NEBRASKA,2010,second_quarter,MED,Medical and biomedical research programs.,"Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2010-07-19T04:59:56.927000-04:00
959964,ace2619e-1771-4645-8890-04bb81b89c4e,Q2,VAN SCOYOC ASSOCIATES,39837,MOUNT DESERT ISLAND BIOLOGICAL LABORATORY,2010,second_quarter,MED,"Department of Defense Appropriations Act, FY2011, Biomedical research.
H.R.5136/S.3454, National Defense Authorization Act, FY2011, Biomedical research.","Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE",20000,,0,0,2010-07-19T05:24:17.787000-04:00
960065,fa2cd650-d654-451d-868c-9178f611a803,Q2,VAN SCOYOC ASSOCIATES,39837,MEDICINES FOR MALARIA VENTURE,2010,second_quarter,MED,"Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2011, USAID research and development related issues and initiatives.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2011, Research and development related issues and initiatives.","Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Agency for International Development (USAID)",30000,,0,0,2010-07-19T06:21:09.207000-04:00